Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Áõ·Ê º¸°í: ¾Ç°ñ¿¡ ¹ß»ýÇÑ ºñ½ºÆ÷½ºÆ÷³×ÀÌÆ® °ü·Ã °ñ±«»çÁõ (BONJ)

Case report : The Bisphosphonate-associated Osteonecrosis of the Jaw(BONJ)

´ëÇѱ¸°­³»°úÇÐȸÁö 2009³â 34±Ç 3È£ p.295 ~ 301
±è±Õ¿ä, °íÀ¯Á¤, ÇãÀ±°æ, ÃÖÀç°©,
¼Ò¼Ó »ó¼¼Á¤º¸
±è±Õ¿ä ( Kim Kyun-Yo ) - °æºÏ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­³»°úÇб³½Ç
°íÀ¯Á¤ ( Ko Yu-Jeong ) - °æºÏ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­³»°úÇб³½Ç
ÇãÀ±°æ ( Hur Yun-Kyung ) - °æºÏ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­³»°úÇб³½Ç
ÃÖÀç°© ( Choi Jae-Kap ) - °æºÏ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­³»°úÇб³½Ç

Abstract

ÃÖ±Ù, °ñ´Ù°øÁõ Ä¡·á ¾à¹°ÀÎ ºñ½ºÆ÷½ºÆ÷³×ÀÌÆ®¿Í °ü·ÃµÈ ¾Ç°ñ±«»çÁõ(BONJ)ÀÌ ±¸°­¾Ç¾È¸é ¿µ¿ª¿¡¼­ ¹ß»ýÇÒ ¼ö ÀÖ´Â »õ·Î¿î ÁúȯÀÇ Çϳª·Î ¶°¿À¸£°í ÀÖ´Ù. ºñ½ºÆ÷½ºÆ÷³×ÀÌÆ®¿Í °ü·ÃµÈ ¾Ç°ñ±«»çÁõÀº ±¸°­³»·Î ³ëÃâµÈ ¾Ç°ñÀÌ °üÂûµÈ ÈÄ 8ÁÖ°¡ Áö³ªµµ ¿ÏÀüÈ÷ Ä¡À¯µÇÁö ¾Ê°í Áö¼ÓµÇ´Â »óŸ¦ ¸»Çϸç, ȯÀÚ´Â ±¸°­¾Ç¾È¸é ¿µ¿ª¿¡ ¹æ»ç¼± Ä¡·á¸¦ ¹ÞÀº º´·ÂÀÌ ¾ø¾î¾ß Çϸç, ºñ½ºÆ÷½ºÆ÷³×ÀÌÆ®·Î Ä¡·á ÁßÀ̰ųª Ä¡·á¹ÞÀº º´·ÂÀÌ ÀÖ¾î¾ß ÇÑ´Ù. ºñ½ºÆ÷½ºÆ÷³×ÀÌÆ®´Â °ñ¿¡ °áÇÕÇÏ´Â ¹°ÁúÀε¥, °ñ°³Á¶°¡ È°¹ßÈ÷ ÀϾ´Â °÷¿¡ °í³óµµ·Î ÁýÀûµÇ¾î Àå±â°£ °ñ°Ý ³»¿¡ ¸Ó¹°¸é¼­ °ñÈí¼ö¸¦ °­·ÂÈ÷ ¾ïÁ¦ÇÏ´Â È¿°ú¸¦ ¹ßÈÖÇÑ´Ù. Çѱ¹¿¡¼­µµ °ñ´Ù°øÁõÀ̳ª ¾ÏȯÀÚ¿¡¼­ °ñÀüÀ̸¦ ¸·±â À§ÇØ ºñ½ºÆ÷½ºÆ÷³×ÀÌÆ®·Î Ä¡·á¸¦ ¹Þ´Â ȯÀÚ°¡ Á¡Â÷ ´Ã°í ÀÖÀ¸¸ç, ÀÌ´Â ¶ÇÇÑ BONJÀÇ ¹ß»ý °¡´É¼ºµµ Áõ°¡ÇÔÀ» ÀǹÌÇÑ´Ù. ¿ì¸®´Â BONJ·Î ÀǽɵǴ ȯÀÚ¸¦ µÎ Áõ·Ê ¼Ò°³ÇÏ°íÀÚ Çϸç, ÀÌ¿Í ÇÔ²² BONJ°¡ ¾î¶² ÁúȯÀ̸ç, BONJ¿¡ ´ëÇÑ Ä¡°úÀÇ»çÀÇ ÀνÄÀÇ Á߿伺À» ¾ð±ÞÇÏ°íÀÚ ÇÑ´Ù. BONJ´Â µå¹°°Ô ¹ß»ýÇÏ´Â ÁúȯÀ̱ä Çϳª, ÀÏ´Ü ¹ß»ýÇÏ¸é ¿¹ÈÄ°¡ ºÒ·®ÇÑ °æ¿ì°¡ ´ëºÎºÐÀÌ´Ù. ±×·¡¼­, BONJ¿¡ ´ëÇÑ ÃæºÐÇÑ ÀÌÇØ°¡ ¾Ç°ñ±«»ç¸¦ ¿¹¹æÇÏ°í, Ä¡·áÇÏ´Â µ¥ ¹Ýµå½Ã ÇÊ¿äÇÒ °ÍÀÌ´Ù.

Recently, bisphosphonate-associated osteonecrosis of the jaw(BONJ) is added to the list of diseases of the oromaxillofacial region. BONJ is defined as exposed bone in the jaw that does not heal within 8 weeks after identification, in a patient who has been received to bisphosphonates and has not taken radiation therapy to the craniofacial region. Bisphosphonates binded to bone mineral are concentrated in highly active remodeling site, reside in the skeleton for a long time, and do a role as powerful inhibitors of bone resorption. As the patients receiving bisphosphonates therapy grow in number, the patients of BONJ would go on increasing in Korea. We would like to present two patients who were suspected to BONJ, describe the outline of BONJ, and mention importance of our understanding about BONJ. BONJ is rare disease, but once it develops, its prognosis is very poor. Our adequate understanding of BONJ is necessary to prevent it and cope with it properly.

Å°¿öµå

ºñ½ºÆ÷½ºÆ÷³×ÀÌÆ®;°ñ±«»çÁõ;°ñ¼ö¿°
Bisphosphonate;Osteomyelitis;Osteonecrosis

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI